Patent directory · USPTO A61K / A61P
Patents matching “hydrogen”
65 pharma patents match "hydrogen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 65 pharmaceutical patents matching "hydrogen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11242510
Mammalian cells devoid of lactate dehydrogenase activity
granted -
US 11225469
Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof
granted -
US 10961200
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10954228
1 H-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10869871
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 10752626
Iso-citrate dehydrogenase (IDH) inhibitor
granted -
US 10738047
Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof
granted -
US 10351532
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted -
US 10131659
Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof
granted -
US 9969719
Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug
granted -
US 9889081
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
granted -
US 9801863
Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
granted -
US 9789116
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 9765055
Intramolecular hydrogen-bonded nitric oxide synthase inhibitors
granted -
US 9713459
Method and system for in vivo hydrogen peroxide detection with ultrasound
granted -
US 9616076
Methods for treating viral infections using hydrogen sulfide donors
granted -
US 9605026
Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
granted -
US 9534007
Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
granted -
US 9504701
Methods for treating viral infections using hydrogen sulfide donors
granted -
US 9399666
Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices
granted -
US 9333264
Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide
granted -
US 9238653
Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
granted -
US 9216983
Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
granted